Phase 1 Psilocybin Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
The RECAP2 Study: Midazolam and Psilocybin
Psilocybin
University of Wisconsin, Madison60 enrolled1 locationNCT06692192
Not Yet Recruiting
Phase 1
Does psilocybin alter the brain's response to food choice and reward?
Psilocybin-induced changes in food rewardPsilocybin-induced changes in food choice
Monash University10 enrolled1 locationACTRN12624000910505
Recruiting
Phase 1Phase 2
Psychedelic-assisted Group Program for First Responders
PsilocybinPsychotherapy, Group
Empower Research Inc32 enrolled1 locationNCT06471959
Completed
Phase 1
PsiConnect: Brain Connectivity and Context under Psilocybin
Neural mechanisms of psilocybin induced altered-states of consciousness
Monash University60 enrolled1 locationACTRN12621001375842